PRXL - Parexel International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRXL - Parexel International

PRXL 88.08

0.0%

Oct 9 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Partmann who wrote (47)	6/25/1999 11:01:00 AM
From: Milk	Read Replies (1) of 62

Merger termination confirmed. BOSTON, June 25 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL - news) today announced that, based on an interim assessment of the Company's results for the fiscal fourth quarter ending June30, 1999, net revenues for the quarter are currently estimated to range between $90 to $93 million; pro forma earnings per share, exclusive of merger-related and other charges, are currently estimated to be in the range of $0.18 to $0.20; and new business authorizations are anticipated to show sequential growth over the third quarter. The Company expects to report actual results for the June quarter, its fiscal year end, in mid-August, consistent with prior years. M.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next